Neuropediatrics, Table of Contents Neuropediatrics 2010; 41(4): 157-162DOI: 10.1055/s-0030-1267155 Review Article© Georg Thieme Verlag KG Stuttgart · New YorkA Practical Guide to Pediatric Multiple SclerosisP. Huppke1 , J. Gärtner1 1Department of Pediatrics and Pediatric Neurology, Georg August University, Göttingen, Germany Recommend Article Abstract Buy Article(opens in new window) Abstract During the past 10 years much knowledge has been gained about multiple sclerosis in the pediatric population. This article summarizes the information relevant to the neurologist and pediatric neurologist concerning the diagnosis, differential diagnosis and therapy for pediatric MS. Key words multiple sclerosis - pediatrics - review Full Text References References 1 Banwell B, Ghezzi A, Bar-Or A. et al . Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet neurology. 2007; 6 887-902 2 Banwell B, Kennedy J, Sadovnick D. et al . Incidence of acquired demyelination of the CNS in Canadian children. Neurology. 2009; 72 232-239 3 Banwell B, Krupp L, Kennedy J. et al . Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet neurology. 2007; 6 773-781 4 Banwell B, Reder AT, Krupp L. et al . Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology. 2006; 66 472-476 5 Banwell B, Shroff M, Ness JM. et al . MRI features of pediatric multiple sclerosis. Neurology. 2007; 68 S46-53 6 Banwell B, Tenembaum S, Lennon VA. et al . Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology. 2008; 70 344-352 7 Boiko A, Vorobeychik G, Paty D. et al . Early onset multiple sclerosis: a longitudinal study. Neurology. 2002; 59 1006-1010 8 Bonhomme GR, Waldman AT, Balcer LJ. et al . Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis. Neurology. 2009; 72 881-885 9 Borriello G, Prosperini L, Luchetti A. et al . Natalizumab treatment in pediatric multiple sclerosis: A case report. Eur J Paediatr Neurol. 2008; 10 Chabas D, Castillo-Trivino T, Mowry EM. et al . Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?. Neurology. 2008; 71 1090-1093 11 Chitnis T, Glanz B, Jaffin S. et al . Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Multiple sclerosis (Houndmills, Basingstoke, England). 2009; 15 627-631 12 Cohen BA, Khan O, Jeffery DR. et al . Identifying and treating patients with suboptimal responses. Neurology. 2004; 63 S33-S40 13 Ghezzi A. Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study. Neurol Sci. 2005; 26 (S 04) S183-S186 14 Ghezzi A, Amato MP, Capobianco M. et al . Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Multiple sclerosis (Houndmills, Basingstoke, England). 2005; 11 420-424 15 Ghezzi A, Banwell B, Boyko A. et al . The management of multiple sclerosis in children: a European view. Multiple sclerosis (Houndmills, Basingstoke, England). 2010; 16 Ghezzi A, Deplano V, Faroni J. et al . Multiple sclerosis in childhood: clinical features of 149 cases. Multiple sclerosis (Houndmills, Basingstoke, England). 1997; 3 43-46 17 Hahn JS, Pohl D, Rensel M. et al . Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurology. 2007; 68 S13-S22 18 Huppke P, Stark W, Zurcher C. et al . Natalizumab use in pediatric multiple sclerosis. Archives of neurology. 2008; 65 1655-1658 19 Kornek B, Bernert G, Balassy C. et al . Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis. Neuropediatrics. 2003; 34 120-126 20 Kriss A, Francis DA, Cuendet F. et al . Recovery after optic neuritis in childhood. Journal of neurology, neurosurgery, and psychiatry. 1988; 51 1253-1258 21 Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007; 68 S7-S12 22 Krupp LB, Macallister WS. Treatment of Pediatric Multiple Sclerosis. Current treatment options in neurology. 2005; 7 191-199 23 Kuker W. Cerebral vasculitis: imaging signs revisited. Neuroradiology. 2007; 49 471-479 24 Lucchinetti CF, Kiers L, O’Duffy A. et al . Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology. 1997; 49 1413-1418 25 Makhani N, Gorman MP, Branson HM. et al . Cyclophosphamide therapy in pediatric multiple sclerosis. Neurology. 2009; 72 2076-2082 26 McAdam LC, Blaser SI, Banwell BL. Pediatric tumefactive demyelination: case series and review of the literature. Pediatric neurology. 2002; 26 18-25 27 McDonald WI, Compston A, Edan G. et al . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of neurology. 2001; 50 121-127 28 McLean BN, Luxton RW, Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. Brain. 1990; 113 (Pt 5) 1269-1289 29 Mikaeloff Y, Adamsbaum C, Husson B. et al . MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain. 2004; 127 1942-1947 30 Mikaeloff Y, Suissa S, Vallee L. et al . First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. The Journal of pediatrics. 2004; 144 246-252 31 Neuteboom RF, Boon M, Catsman Berrevoets CE. et al . Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology. 2008; 71 967-973 32 Pittock SJ, Lennon VA, Krecke K. et al . Brain abnormalities in neuromyelitis optica. Archives of neurology. 2006; 63 390-396 33 Pohl D, Rostasy K, Gartner J. et al . Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology. 2005; 64 888-890 34 Pohl D, Rostasy K, Reiber H. et al . CSF characteristics in early-onset multiple sclerosis. Neurology. 2004; 63 1966-1967 35 Pohl D, Rostasy K, Treiber-Held S. et al . Pediatric multiple sclerosis: detection of clinically silent lesions by multimodal evoked potentials. The Journal of pediatrics. 2006; 149 125-127 36 Pohl D, Waubant E, Banwell B. et al . Treatment of pediatric multiple sclerosis and variants. Neurology. 2007; 68 S54-S65 37 Polman CH, Reingold SC, Edan G. et al . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Annals of neurology. 2005; 58 840-846 38 Renoux C, Vukusic S, Mikaeloff Y. et al . Natural history of multiple sclerosis with childhood onset. The New England journal of medicine. 2007; 356 2603-2613 39 Riikonen R, Donner M, Erkkila H. Optic neuritis in children and its relationship to multiple sclerosis: a clinical study of 21 children. Developmental medicine and child neurology. 1988; 30 349-359 40 Sellner J, Luthi N, Buhler R. et al . Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis. Eur J Neurol. 2008; 15 398-405 41 Stark W, Huppke P, Gartner J. Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence. Journal of neurology. 2008; 255 (S 06) 119-122 42 Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 2002; 59 1224-1231 43 Tenembaum S, Chitnis T, Ness J. et al . Acute disseminated encephalomyelitis. Neurology. 2007; 68 S23-S36 44 Tenembaum SN, Segura MJ. Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology. 2006; 67 511-513 45 Waubant E, Chabas D. Pediatric multiple sclerosis. Current treatment options in neurology. 2009; 11 203-210 46 Waubant E, Chabas D, Okuda DT. et al . Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs. adults. Archives of neurology. 2009; 66 967-971 47 Waubant E, Hietpas J, Stewart T. et al . Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics. 2001; 32 211-213 48 Wingerchuk DM, Hogancamp WF, O’Brien PC. et al . The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999; 53 1107-1114 49 Yeh EA, Chitnis T, Krupp L. et al . Pediatric multiple sclerosis. Nat Rev Neurol. 2009; 5 621-631 Correspondence Peter HuppkeMD Department of Pediatrics and Pediatric Neurology Georg August University Faculty of Medicine Robert-Koch-Straße 40 37075 Göttingen Germany Phone: +49/551/396 210 Fax: +49/551/396 252 Email: phuppke@med.uni-goettingen.de
